Haploidentical stem cell transplantation as a salvage therapy for cord blood engraftment failure in a patient with fanconi anemia

Pediatric Blood and Cancer

Volumn 55, Issue 3, 2010, Pages 580-582

  Rihani, Rawad ^a   Lataifeh, Isam ^b   Halalsheh, Hadeel ^a   Hussein, Ayad Ahmed ^a   Al Zaben, Abdulhadi ^a   Abdel Rahman, Fawzi ^a   Sarhan, Mahmoud ^a  

^a KING HUSSEIN CANCER CENTER   (Jordan)

^b JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

2 locus mismatched transplantation; Cord blood transplantation; Fanconi anemia; Graft failure; Second stem cell transplantations

Indexed keywords

ARTICLE; BLOOD CELL COUNT; CASE REPORT; CHILD; CHIMERA; FANCONI ANEMIA; FATHER; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; MALE; PRIORITY JOURNAL; SALVAGE THERAPY; SCHOOL CHILD; T LYMPHOCYTE; TREATMENT INDICATION; TREATMENT OUTCOME; UMBILICAL CORD BLOOD; CORD BLOOD STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY;

CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; FANCONI ANEMIA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMANS; MALE; SALVAGE THERAPY;

EID: 77955481707     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22584     Document Type: Article

References (20)

1. Gluckman E. Bone marrow transplantation in Fanconi's anemia. Stem Cells 1993;11:180-183. (Pubitemid 23331573)
2. Gluckman E, Wagner JE. Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndrome. Bone Marrow Transplant 2008;41:127-132. (Pubitemid 351188909)
3. Gluckman E, Rocha V, Ionescu I, et al. Results of unrelated cord blood transplant in fanconi anemia patients: Risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant 2007;13: 1073-1082.
4. Socie G, Devergie A, Girinski T, et al. Transplantation for Fanconi's anaemia: Long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning. Br J Haematol 1998;103:249-255. (Pubitemid 28470827)
5. Ayas M, Al-Jefri A, Al-Seraihi A, et al. Second stem cell transplantation in patients with Fanconi anemia using antithymocyte globulin alone for conditioning. Biol Blood Marrow Transplant 2008;14:445-448. (Pubitemid 351372754)
6. Mattsson J, Ringden O, Storb R. Graft failure after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2008;14:165-170. (Pubitemid 350286854)
7. Kernan NA, Bordignon C, Heller G, et al. Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants. Blood 1989;74:2227-2236.
8. Ayas M, Al-Jefri A, Al-Seraihi A, et al. Allogeneic stem cell transplantation in Fanconi anemia patients presenting with myelodysplasia and/or clonal abnormality: Update on the Saudi experience. Bone Marrow Transplant 2008;41:261-265.
9. Wagner JE, Eapen M, MacMillan ML, et al. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood 2007;109:2256-2262. (Pubitemid 46348231)
10. Davies SM, Weisdorf DJ, Haake RJ, et al. Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994;14:73-77. (Pubitemid 24228741)
11. Guardiola P, Kuentz M, Garban F, et al. Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. French Society of Bone Marrow Transplantation. Br J Haematol 2000;111:292-302.
12. Terenzi A, Aristei C, Aversa F, et al. Efficacy of fludarabine as an immunosuppressor for bone marrow transplantation conditioning: Preliminary results. Transplant Proc 1996;28:3101. (Pubitemid 26415410)
13. Wagner JE, Eapen M, MacMillan ML, et al. Unrelated donor bone marrowtransplantation for the treatment of Fanconi anemia. Blood 2007;109:2256-2262.
14. Locatelli F, Zecca M, Pession A, et al. The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: A report from the Italian pediatric group. Haematologica 2007;92:1381-1388.
15. Chewning JH, Castro-Malaspina H, Jakubowski A, et al. Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure. Biol Blood Marrow Transplant 2007;13:1313-1323.
16. Ichinohe T, Uchiyama T, Shimazaki C, et al. Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microchimerism. Blood 2004;104:3821-3828.
17. Inagaki J, Park YD, Kishimoto T, et al. Successful unmanipulated haploidentical bone marrow transplantation from an HLA 2-locus-mismatched mother for Wiskott-Aldrich syndrome after unrelated cord blood stem cell transplantation. J Pediatr Hematol Oncol 2005;27:229-231.
18. Grandage VL, Cornish JM, Pamphilon DH, et al. Second allogeneic bone marrow transplants from unrelated donors for graft failure following initial unrelated donor bone marrow transplantation. Bone Marrow Transplant 1998;21:687-690.
19. Min CK, Kim DW, Lee JW, et al. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose. Haematologica 2001;86:303-310.
20. Remberger M, Ringden O, Ljungman P, et al. Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998;22:73-78.